Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.0B | 2.4B | 2.6B |
Cost of revenue | 1.1B | 1.0B | 1.2B | 1.3B |
Gross profit | 1.0B | 995.6M | 1.2B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 402.4M | 360.6M | 451.2M | 440.0M |
Operating income | 172.9M | 106.0M | 191.9M | 253.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 43.4M | 49.3M | 56.5M | 64.5M |
Other income expense | — | — | — | — |
Pretax income | 172.5M | 87.7M | 154.4M | 213.1M |
Tax provision | 75.3M | 19.0M | 59.0M | 70.8M |
Net income | 97.2M | 68.7M | 95.4M | 142.4M |
Basic EPS | — | 3.7 | 5.1 | 7.6 |
Diluted EPS | — | 3.7 | 5.1 | 7.6 |
Basic average shares | — | 18.8M | 18.7M | 18.8M |
Diluted average shares | — | 18.8M | 18.8M | 18.8M |
EBITDA | 375.2M | 296.4M | 370.9M | 433.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |